Skip to main content
Equibles

Bellevue Group AG

Position in AGMB — Agomab Therapeutics NV

CIK 1674546 Zurich, V8
Back to AGMB Full portfolio

Position in AGMB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$639,239
+$114,739 QoQ
Shares Held
49,248
-1.5% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 34 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AGMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. AGMB ranks #44 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 578,634 $287,424,866
2 ARGX
Argenx SE
 301,000 $279,258,770
3 RVMD
Revolution Medicines, Inc.
 1,048,014 $196,272,061
4 ORKA
Oruka Therapeutics, Inc.
 1,657,190 $157,714,772
5 INSM
INSMED Inc
 1,393,418 $148,566,226
6 SRRK
Scholar Rock Holding Corp
 2,449,547 $134,725,085
7 VRDN
Viridian Therapeutics, Inc.\DE
 6,731,909 $123,665,167
8 RLAY
Relay Therapeutics, Inc.
 6,185,970 $115,739,498

All Filings in AGMB

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $639,239 49,248
2026-03-31 $524,500 50,000